Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography
Recruiting
N/A
Interventional Study
Neuromuscular Blockade
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 6 Months – 2
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- Matias Vested · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to compare AMG and EMG (Philips IntelliVue NMT module and Senzime TetraGraph) in the objective monitoring of neuromuscular blocking in children between the age of 6 months and 2 years.The monitoring will be done bilaterally either on n.ulnaris or n. tibialis. The hypothesis of the study is that AMG will indicate faster recovery time (time to return to TOF 90%) from neuromu…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients 6 months - 2 years of age
* Scheduled for elective surgery under general anaesthesia with intubation and use of rocuronium
* American Society of Anesthesiologists (ASA) physical status classification I to III
Exclusion Criteria:
* Known allergy to rocuronium
* Neuro…
Contacts